دورية أكاديمية

PRDX3 is associated with metastasis and poor survival in uveal melanoma.

التفاصيل البيبلوغرافية
العنوان: PRDX3 is associated with metastasis and poor survival in uveal melanoma.
المؤلفون: Ramasamy P; Department of Ophthalmology, Royal College of Surgeons in Ireland, Dublin, Ireland pathmaramasamy@rcsi.ie.; National Institute for Cellular Biotechnology, Dublin, Ireland.; Royal Victoria Eye and Ear Hospital, Dublin, Ireland., Larkin AM; National Institute for Cellular Biotechnology, Dublin, Ireland.; Department of Life Sciences, Institute of Technology Sligo, Sligo, Ireland., Linge A; National Institute for Cellular Biotechnology, Dublin, Ireland., Tiernan D; Royal Victoria Eye and Ear Hospital, Dublins, Ireland., McAree F; Royal Victoria Eye and Ear Hospital, Dublins, Ireland., Horgan N; Royal Victoria Eye and Ear Hospital, Dublins, Ireland., Moriarty P; Royal Victoria Eye and Ear Hospital, Dublins, Ireland., Beatty S; Waterford Institute of Technology, Waterford, Ireland., Murphy CC; Department of Ophthalmology, Royal College of Surgeons in Ireland, Dublin, Ireland.; Royal Victoria Eye and Ear Hospital, Dublins, Ireland., Clynes M; National Institute for Cellular Biotechnology, Dublin, Ireland.; Synthesis and Solid State Pharmaceutical Centre, Science Foundation Ireland, Dublin, Ireland., Kennedy S; Histopathology, Royal Victoria Eye and Ear Hospital, Dublin, Ireland., Meleady P; National Institute for Cellular Biotechnology, Dublin, Ireland.
المصدر: Journal of clinical pathology [J Clin Pathol] 2020 Jul; Vol. 73 (7), pp. 408-412. Date of Electronic Publication: 2019 Nov 26.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: BMJ Pub. Group Country of Publication: England NLM ID: 0376601 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1472-4146 (Electronic) Linking ISSN: 00219746 NLM ISO Abbreviation: J Clin Pathol Subsets: MEDLINE
أسماء مطبوعة: Publication: London : BMJ Pub. Group
Original Publication: London : British Medical Association
مواضيع طبية MeSH: Melanoma/*diagnosis , Peroxiredoxin III/*metabolism , Uveal Neoplasms/*diagnosis, Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Immunohistochemistry ; Kaplan-Meier Estimate ; Male ; Melanoma/metabolism ; Melanoma/pathology ; Middle Aged ; Neoplasm Metastasis ; Paraffin Embedding ; Prognosis ; Retrospective Studies ; Tissue Array Analysis ; Uveal Neoplasms/metabolism ; Uveal Neoplasms/pathology ; Young Adult
مستخلص: Aims: Uveal melanoma (UM) is the most common primary intraocular malignancy in adults, and 40% develop fatal metastatic disease. Overexpression of thioredoxin-dependent peroxidase reductase (PRDX3) has been implicated in several cancers, including prostate, breast, colorectal and lung cancer. The aim of this study was to compare the immunohistochemical expression of PRDX3 in formalin-fixed, paraffin-embedded (FFPE) primary UM tissues of patients who did and did not develop metastatic disease.
Methods: Immunohistochemical staining of PRDX3 was performed on FFPE tissue microarray samples of 92 primary UM tumours from patients who did and did not develop metastatic disease. The immunohistochemical staining was assessed by two observers who were blinded to all clinicopathological and cytogenetic details including metastatic/non-metastatic information. Based on a scoring system, expression of PRDX3 was graded as high or low.
Results: There were 55 tumours (59.8%) from patients who developed metastatic disease, while 37 (40.2%) were from patients who did not develop metastasis. A statistically significant difference in PRDX3 expression was observed in patients who did and did not develop metastasis (p=0.001). A significant positive correlation between high PRDX3 expression and metastasis was observed (p=0.001). A significant negative correlation between PRDX3 expression and survival was found (p=0.005). Kaplan-Meier survival analysis showed a statistically significant difference in overall survival between tumours that demonstrated low and high expression of PRDX3 (67.61 vs 130.64 months, respectively, p=0.013).
Conclusions: High immunohistochemical expression of PRDX3 in primary UM tissue is associated with metastasis and poor survival.
Competing Interests: Competing interests: None declared.
(© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.)
فهرسة مساهمة: Keywords: malignant tumours; metastasis; oncology; ophthalmology; uveal melanoma
المشرفين على المادة: EC 1.11.1.15 (PRDX3 protein, human)
EC 1.11.1.15 (Peroxiredoxin III)
SCR Disease Name: Uveal melanoma
تواريخ الأحداث: Date Created: 20191128 Date Completed: 20200706 Latest Revision: 20200706
رمز التحديث: 20231215
DOI: 10.1136/jclinpath-2019-206173
PMID: 31771972
قاعدة البيانات: MEDLINE
الوصف
تدمد:1472-4146
DOI:10.1136/jclinpath-2019-206173